Page last updated: 2024-08-25

orotirelin and 3,4-dihydroxyphenylacetic acid

orotirelin has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, GW; Brazell, MP; Marsden, CA; Sharp, T1

Other Studies

1 other study(ies) available for orotirelin and 3,4-dihydroxyphenylacetic acid

ArticleYear
The TRH analogue CG3509 increases in vivo catechol/ascorbate oxidation in the N. accumbens but not in the striatum of the rat.
    Neuropharmacology, 1984, Volume: 23, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Catechols; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Nucleus Accumbens; Oxidation-Reduction; Rats; Rats, Inbred Strains; Septal Nuclei; Thyrotropin-Releasing Hormone

1984